Authors

• Michal Schnaider Beeri (ORCID: https://orcid.org/0000-0002-4254-9742)
• Kamille Janess (ORCID: https://orcid.org/0000-0001-5771-4133)
• Laura Thi Germine (ORCID: https://orcid.org/0000-0001-8690-8412)
• Laneé Jung (ORCID: https://orcid.org/0000-0003-3555-5287)
• Zoë Hawks (ORCID: https://orcid.org/0000-0002-3796-0289)
• Shafaq Rizvi
• Naomi Chaytor (ORCID: https://orcid.org/0000-0001-8821-289X)
• Richard E. Pratley (ORCID: https://orcid.org/0000-0002-2912-1389)
• Yogish C. Kudva (ORCID: https://orcid.org/0000-0003-0285-6622)
• Jane Bulger (ORCID: https://orcid.org/0000-0002-3585-4896)
• Ruth S. Weinstock (ORCID: https://orcid.org/0000-0001-5859-5666)
• Luciana Mascarenhas Fonseca (ORCID: https://orcid.org/0000-0002-2849-0545)
• Elizabeth Grinspoon (ORCID: https://orcid.org/0000-0002-5608-8254)
• Pia Webb Kivisäkk
• Jasmeer P. Chhatwal
• Martin Sliwinski
• Doug L. Weeks
• Michael R. Rickels
• Michael Cleveland

Institutions

• Pennsylvania State University (US)
• Translational Research Institute (AU)
• Allen Institute for Brain Science (US)
• Harvard University (US)
• Washington State University Spokane (US)
• SUNY Upstate Medical University (US)
• McLean Hospital (US)
• Massachusetts General Hospital (US)
• Jaeb Center for Health Research (US)
• Washington State University (US)
• University of Pennsylvania (US)

Publication Details

Journal

Neuropsychology

Published

2026-04-27

DOI

https://doi.org/10.1037/neu0001080

Primary Topic

Dementia and Cognitive Impairment Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Alzheimer's Association
• Amgen
• Eli Lilly and Company
• University of Pennsylvania
• University of Washington
• Insulet Corporation
• MannKind Corporation
• Dexcom
• Novo Nordisk
• National Institutes of Health
• National Institute of Diabetes and Digestive and Kidney Diseases
• National Center for Advancing Translational Sciences